Gilead Sciences (GILD)

Outperform Recap: Q2 2026

PrEP Clears $1B a Quarter and Persistency Finally Has a Number, But the Revenue Raise Never Reaches EPS

Outperform Recap: Q1 2026

Gilead Beats, Raises, and Falls Anyway on $11.5B of M&A Charges: Upgrading to Outperform

Hold Recap: Q4 2025

Gilead Beats and Prints a Record High, But the 2026 Guide Lands Light: Initiating at Hold